Auris recently announced the development of the AM-301 nasal spray for protection against SARS-COV-2 (COVID-19) infection (though it is also intended to protect against other airborne pathogens and allergens as well). AM-301 is a gel that would form a protective layer in the nasal mucosa, preventing contact between the pathogen and cells. In vitro data so far suggest contact between AM-301 and COVID-19 reduced the viral load by up to 99%. The company is targeting regulatory submission as an o
18 Sep 2020
Auris Medical Holding - A nasal spray to help protect against COVID-19
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Auris Medical Holding - A nasal spray to help protect against COVID-19
Altamira Therapeutics Ltd. (CYTO:NAS) | 0 0 0.0%
- Published:
18 Sep 2020 -
Author:
Maxim Jacobs -
Pages:
5
Auris recently announced the development of the AM-301 nasal spray for protection against SARS-COV-2 (COVID-19) infection (though it is also intended to protect against other airborne pathogens and allergens as well). AM-301 is a gel that would form a protective layer in the nasal mucosa, preventing contact between the pathogen and cells. In vitro data so far suggest contact between AM-301 and COVID-19 reduced the viral load by up to 99%. The company is targeting regulatory submission as an o